Magnesium sulfate as a second-line tocolytic agent for preterm labor: a randomized controlled trial in Kyushu Island

Yasuyuki Kawagoe, Hiroshi Sameshima, Tsuyomu Ikenoue, Ichiro Yasuhi, Tatsuhiko Kawarabayashi, Yasuyuki Kawagoe, Hiroshi Sameshima, Tsuyomu Ikenoue, Ichiro Yasuhi, Tatsuhiko Kawarabayashi

Abstract

Objectives: We evaluated the efficacy of magnesium sulfate as a second-line tocolysis for 48 hours.

Materials and methods: A multi-institutional, simple 2-arm randomized controlled trial was performed. Forty-five women at 22 to 34 weeks of gestation were eligible, whose ritodrine did not sufficiently inhibit uterine contractions. After excluding 12 women, 33 were randomly assigned to either magnesium alone or combination (ritodrine and magnesium). The treatment was determined as effective if the frequency of uterine contraction was reduced by 30% at 48 hours of the treatment.

Results: After magnesium sulfate infusion, 90% prolonged their pregnancy for >48 hours. Combination therapy was effective in 95% (18/19), which was significantly higher than 50% (7/14) for magnesium alone.

Conclusion: This randomized trial revealed that combination therapy significantly reduced uterine contractions, suggesting that adjuvant magnesium with ritodrine is recommended, rather than changing into magnesium alone, when uterine contractions are intractable with ritodrine infusion.

Figures

Figure 1
Figure 1
Flowchart of a simple 2-arm randomized controlled trial.
Figure 2
Figure 2
Temporal changes in uterine contractions after the start of magnesium sulfate treatment in the magnesium-alone group (a) and combination group (b). The dotted lines in the magnesium-alone group represent those who required reinfusion of ritodrine to inhibit uterine contraction. Asterisks represent those who delivered within 48 hours of magnesium infusion.

References

    1. Crowther CA, Hiller JE, Doyle LW. Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews. 2002;(4, article CD001060)
    1. Mercer BM, Merlino AA. Magnesium sulfate for preterm labor and preterm birth. Obstetrics and Gynecology. 2009;114(3):650–668.
    1. Ikenoue T, Matsuda Y, Kamitomo M, Hokanishi H. Combination therapy of intravenous ritodrine and magnesium sulfate to inhibit premature labor. The Journal of Obstetrics and Gynaecology Research. 1989;41(12):1972–1978.
    1. Coleman FH. Safety and efficacy of combined ritodrine and magnesium sulfate for preterm labor: a method for reduction of complications. American Journal of Perinatology. 1990;7(4):366–369.
    1. Kosasa TS, Busse R, Wahl N, Hirata G, Nakayama RT, Hale RW. Long-term tocolysis with combined intravenous terbutaline and magnesium sulfate: a 10-year study of 1000 patients. Obstetrics and Gynecology. 1994;84(3):369–373.
    1. Ogburn PL, Jr., Hansen CA, Williams PP, Butler JC, Jr., Joseph MS, Julian TM. Magnesium sulfate and beta-mimetic dual-agent tocolysis in preterm labor after single-agent failure. The Journal of Reproductive Medicine. 1985;30(8):583–587.
    1. Hatjis CG, Nelson LH, Meis PJ, Swain M. Addition of magnesium sulfate improves effectiveness of ritodrine in preventing premature delivery. American Journal of Obstetrics and Gynecology. 1984;150(2):142–150.
    1. Ferguson JE, II, Hensleigh PA, Kredenster D. Adjunctive use of magnesium sulfate with ritodrine for preterm labor tocolysis. American Journal of Obstetrics and Gynecology. 1984;148(2):166–171.
    1. Lencki SG, Maciulla MB, Eglinton GS. Maternal and umbilical cord serum interleukin levels in preterm labor with clinical chorioamnionitis. American Journal of Obstetrics and Gynecology. 1994;170(5, part 2):1345–1351.
    1. Casper RF, Lye SJ. Myometrial desensitization to continuous but not to intermittent beta-adrenergic agonist infusion in the sheep. American Journal of Obstetrics and Gynecology. 1986;154(2):301–305.
    1. Lye SJ, Dayes BA, Freitag CL, Brooks J, Casper RF. Failure of ritodrine to prevent preterm labor in the sheep. American Journal of Obstetrics and Gynecology. 1992;167(5):1399–1408.
    1. Caritis SN, Chiao JP, Moore JJ, Ward SM. Myometrial desensitization after ritodrine infusion. American Journal of Physiology. 1987;253(4):E410–E417.
    1. Kawarabayashi T, Tsukamoto T, Kaneko Y, Ikeda M, Sugimori H, Shirakawa K. Changes in beta-adrenergic receptors under long-term application of ritodrine in pregnant-rat myometrium. Gynecologic and Obstetric Investigation. 1993;35(3):136–139.
    1. Kawarabayashi T, Ikeda M, Sugimori H, Nakano H. Effects of magnesium and catecholamines on spontaneous contraction of pregnant human isthmic myometrium. Asia-Oceania Journal of Obstetrics and Gynaecology. 1984;10(3):375–384.

Source: PubMed

Sponsors and Collaborators

Medical Conditions

Drug Interventions

3
Subscribe